Sun. Nov 22nd, 2026

More than 60 civil and human rights, faith and criminal justice reform organizations, including the ACLU, Human Rights Watch, NAACP, FAMM, Drug Policy Alliance, and the Sentencing Project, have sent a letter to the House Judiciary Committee opposing HR 2851, the Stop the Importation and Trafficking of Synthetic Analogues Act of 2017.

The proposal signals that the federal government still has not broken its addiction to repressive and ineffective prohibitionist policies.

The  bill, sponsored by Rep Katko (R-NY) and Rep Rice (D-NY), is part of Attorney General Jeff Sessions’ effort to reinvigorate the failed and discredited Drug War. HR 2851 would hand Sessions sweeping power to schedule new drugs, and set the corresponding penalties. It also includes new mandatory minimums. Senators Grassley and Feinstein have introduced a similar bill in the Senate.

Feinstein supports harsher penalties for all

Feinstein
Senator Feinstein can’t see anything wrong with prohibition sending drug addicts and cannabis users to prison.

“This is just another example of how far out of touch Feinstein is from her constituents and from reality itself, in terms of drug policy,” said Chris Conrad of the Family Council on Drug Awareness. “California voters passed Proposition 215 legalizing medical marijuana in 1996 and now, 21 years later, Feinstein has still done nothing to represent us. No legislation offered to reschedule or deschedule cannabis, no support for research, no respect for the voters — no relief whatever except a weak-spined ‘CBD-only’ bill that has never made it out of committee.

“Feinstein is a disgrace,” added Conrad. “She skates on her reputation as a San Francisco Democrat while, in reality, she is still in bed with the most ignorant and repressive drug warriors. Her track record is shameful. The Democrats would do well to dump her next time around, and if they don’t, then it’s up to California voters to toss her out of office.”

Bills take a ‘backwards approach’

The opposition letter reads, in part, “The proposed legislation is a backwards approach to addressing the country’s drug problem by ignoring evidence of effective drug interventions and countering the common public sentiment that embraces treatment over incarceration as the right approach to the opioid epidemic.”

Most opioid addicts enter through the gateway of legal prescription pharmaceutical drugs, typically for pain, and some shift over to less expensive street drugs, particularly if they are cut off from their prescriptions before they have their pain under control. Due to policies that punish pain doctors for writing the kinds of prescriptions that many pain patients require, people are often stigmatized and left to fend for themselves, which results in predictable societal problems.

DPA urges more effective remedies

pharma, pharmaceutical, pills, meds, synthetics“While we share the Representatives’ concern about the rise in fatalities linked to synthetic drugs, this bill takes the wrong approach,” said Michael Collins, Deputy Director of the Drug Policy Alliance’s Office of National Affairs.

“We know that more incarceration will fail to tackle the opioid epidemic, and we know that more treatment and overdose prevention are approaches that work. Giving any Attorney General broad power to decide which substances should be banned and which penalties apply is incredibly dangerous and misguided.”

Current research shows that legalizing cannabis helps to reduce opioid use and car accidents related to the use of pain pills.

By WCL News Service

TheLeafOnline (formerly West Coast Leaf), staff produces bylined content and we also select certain key reports and press materials that we edit, refine, contextualize and post. When efforts combine the writings of multiple contributors, we credit the WCL News Service. Otherwise, the author's name is posted on the story.